Search results
27 Results for 'Collaborations'
- Technologies (0)
- Collaborations (14)
- Team (0)
- News (8)
- Pages (0)
- Multimedia (5)
- Publications (0)
- Jobs (0)
- Events (0)
Collaborations 14
-
Global Development Program
A Solid Foundation The Boston-Cambridge ecosystem, home to numerous prestigious academic institutions, top-tier hospitals, and leaders in the biopharmaceutical industry, is one of the most productive biomedical research ecosystems on earth. The Wyss Institute sits at the nexus of this bustling research-clinical-industry cluster. A powerhouse of cutting-edge research and translation since its founding, the Wyss... -
Nucleic Acid Delivery Consortium
An academic-industry consortium focused on the challenge of delivering nucleic acid-based therapies to specific target organs, tissues, and cells. -
Scientific Instrumentation @ Wyss Collaboratories Program
The Wyss Scientific Instrumentation @ Wyss Collaboratories Program is a unique collaboration between industry manufacturers and our community of scientists and engineers to drive progress and impact, spur entrepreneurship, and incubate innovation. -
Brain Targeted Therapeutic Collaboration
Combine our shuttles with your drugs to create new brain targeted therapeutics for patients. -
Brain Shuttle Research Sponsorship & Licensing
Enabling brain-targeted drug development through non-exclusive licensing and pre-competitive research sponsorship. -
Bridging the Funding Gap for Brain Therapeutics
A unique opportunity to help develop a new generation of brain targeted drugs
News 8
Multimedia 5
-
Video/AnimationReimagine the World – Volume 3 – Northpond EditionThe Wyss Institute’s alliance with Northpond Labs supports early-stage, transformative research with strong translation potential. Hear Northpond Ventures co-founders Michael Rubin and Sharon Kedar explain why they decided to partner with the Wyss, as well as the leaders of various Wyss projects and startups about how support from Northpond has helped accelerate their technologies to... -
Audio/PodcastMaking Sugar Healthier – DDN DialoguesWith some out-of-the-box engineering, researchers have developed a nature-inspired strategy to turn sugar in packaged foods into gut-healthy fiber. This podcast features Director of Business Development, Sam Inverso, Ph.D., and Senior Engineer Adama Sesay, Ph.D., along with Judith Moca and John Topinka from Kraft-Heinz. This episode was created and is owned by Drug Discovery News,... -
Video/AnimationReimagine the World – Volume 2 – Diagnostics AcceleratorTwo clinicians collaborating with the Wyss Diagnostics Accelerator (DxA), Lise Johnson and Craig Hersh, as well as two members of the Wyss DxA Industrial Partnership Program, Nell Meosky Luo and Andy Levin, share how they would Reimagine the World and the personal stories that fuel their passion for the work they are doing. Credit: Wyss... -
Video/AnimationWyss Diagnostics Accelerator – The Industrial Participant ProgramThe Industrial Participant Program (IPP) is a collaboration hub between healthcare testing companies and the scientific and clinical community within the Wyss ecosystem, driven by the Wyss Diagnostics Accelerator (DxA). Members of the IPP share the common goal of fast-tracking diagnostic technologies to meet unmet, critical needs. Credit: Wyss Institute at Harvard University -
Video/AnimationReimagining Health Equity: Wyss Diagnostics AcceleratorWith the Wyss Diagnostics Accelerator (DxA), we’re reimagining health equity by accelerating the development and deployment of needed diagnostics in all settings, particularly in low-resource settings, by fostering deep collaborations driven by unmet needs. Credit: Wyss Institute at Harvard University